Vasundhara Rasy.

{
  "main_header": {
    "sid": 552857,
    "name": "Vasundhara Rasy.",
    "stock_name": "Vasundhara Rasy.",
    "full_name": "Vasundhara Rasayans Ltd",
    "name_url": "stocks-analysis/vasundhara-rasy",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "155.95",
    "chg": 4.55,
    "chgp": "3.01%",
    "dir": 1,
    "prev_price": "151.40",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538634,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE406F01010",
    "curr_date": "Jan 20",
    "curr_time": "",
    "bse_nse_vol": "389 ",
    "exc_status": "Active",
    "traded_date": "Jan 20, 2026",
    "traded_date_str": "2026 01 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vasundhara-rasy-552857-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.145",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-stock-falls-to-52-week-low-of-rs145-3794471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VasundharaRasay_priceRelatedfactors_3794471.png",
        "date": "2026-01-19 10:35:57",
        "description": "Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.145 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector and market benchmarks, reflecting ongoing pressures on its valuation and market sentiment."
      },
      {
        "title": "Vasundhara Rasayans Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-ltd-is-rated-strong-sell-3791657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VasundharaRasay_mojoScore_3791657.png",
        "date": "2026-01-14 10:10:54",
        "description": "Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Vasundhara Rasayans Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vasundhara-rasayans-ltd-fallingrising-3785964",
        "imagepath": "",
        "date": "2026-01-09 02:22:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>On 08 January, Vasundhara Rasayans Ltd closed at ₹162.00, down ₹2.45 or 1.49% from the previous session. This decline is part of a broader trend, with the stock having fallen for four consecutive days, resulting in a cumulative loss of 7.32% over this period. The intraday low touched ₹160, marking a 2.71% drop within the trading session. Notably, the stock has underperformed its sector by 1.03% today, signalling weaker investor sentiment compared to its industry peers.</p>\n<p>Further technical indicators reinforce this bearish outlook. The share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting persistent downward momentum and a lack of short-term buying i..."
      },
      {
        "title": "Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-stock-falls-to-52-week-low-of-rs1463-3776299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VasundharaRasay_priceRelatedfactors_3776299.png",
        "date": "2025-12-31 11:21:25",
        "description": "Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-stock-falls-to-52-week-low-of-rs1463-3776302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VasundharaRasay_priceRelatedfactors_3776302.png",
        "date": "2025-12-31 11:21:24",
        "description": "Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Vasundhara Rasayans Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-ltd-is-rated-strong-sell-3772929",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VasundharaRasay_mojoScore_3772929.png",
        "date": "2025-12-29 10:10:52",
        "description": "Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Vasundhara Rasayans: Analytical Perspective Shifts Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3761910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VasundharaRasay_mojoScore_3761910.png",
        "date": "2025-12-18 08:06:11",
        "description": "Vasundhara Rasayans, a player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Vasundhara Rasy. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasy-downgraded-to-strong-sell-amid-valuation-and-quality-concerns-3749858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VasundharaRasy_mojoScore_3749858.png",
        "date": "2025-12-06 10:10:14",
        "description": "Vasundhara Rasy., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial trends, valuation, quality metrics, and technical outlook, highlighting the complexities investors face in assessing smaller-cap stocks within this dynamic sector."
      },
      {
        "title": "Is Vasundhara Rasy. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vasundhara-rasy-overvalued-or-undervalued-3747603",
        "imagepath": "",
        "date": "2025-12-05 08:23:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and Financial Ratios</strong></p>\n<p>At a price-to-earnings (PE) ratio of approximately 13.4, Vasundhara Rasy. trades at a moderate premium relative to many peers in its industry. Its price-to-book value stands at 1.71, indicating that the market values the company at nearly twice its book value. The enterprise value to EBITDA ratio of 14.8 further suggests a relatively elevated valuation, though not excessively so when compared to the broader pharmaceutical sector.</p>\n<p>Return on capital employed (ROCE) and return on equity (ROE) are important indicators of operational efficiency and profitability. Vasundhara Rasy. posts a ROCE of 10.75% and an ROE of 12.74%, reflecting decent returns but not exceptional when benchmarked against industry leaders. The dividend yield of 1...."
      }
    ],
    "total": 223,
    "sid": "552857",
    "stock_news_url": "https://www.marketsmojo.com/news/vasundhara-rasayans-552857"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Dec-2025",
      "details": "Intimation regarding the closure of trading window for the quarter ended as on 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Termination Of Lease And License Agreement .",
      "datetime": "29-Dec-2025",
      "details": "Intimation regarding termination of Lease and License agreement with VN creative chemicals Private Limited .",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Newspaper Publication of Financial Results for the Quarter and Half year ended on 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vasundhara Rasayans Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.145

2026-01-19 10:35:57

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.145 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector and market benchmarks, reflecting ongoing pressures on its valuation and market sentiment.

Read full news article

Vasundhara Rasayans Ltd is Rated Strong Sell

2026-01-14 10:10:54

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Vasundhara Rasayans Ltd falling/rising?

2026-01-09 02:22:31

Recent Price Movement and Market Performance

On 08 January, Vasundhara Rasayans Ltd closed at ₹162.00, down ₹2.45 or 1.49% from the previous session. This decline is part of a broader trend, with the stock having fallen for four consecutive days, resulting in a cumulative loss of 7.32% over this period. The intraday low touched ₹160, marking a 2.71% drop within the trading session. Notably, the stock has underperformed its sector by 1.03% today, signalling weaker investor sentiment compared to its industry peers.

Further technical indicators reinforce this bearish outlook. The share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting persistent downward momentum and a lack of short-term buying i...

Read full news article

Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3

2025-12-31 11:21:25

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3

2025-12-31 11:21:24

Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

Vasundhara Rasayans Ltd is Rated Strong Sell

2025-12-29 10:10:52

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Vasundhara Rasayans: Analytical Perspective Shifts Amidst Mixed Financial and Technical Signals

2025-12-18 08:06:11

Vasundhara Rasayans, a player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing.

Read full news article

Vasundhara Rasy. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-06 10:10:14

Vasundhara Rasy., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial trends, valuation, quality metrics, and technical outlook, highlighting the complexities investors face in assessing smaller-cap stocks within this dynamic sector.

Read full news article

Is Vasundhara Rasy. overvalued or undervalued?

2025-12-05 08:23:03

Valuation Metrics and Financial Ratios

At a price-to-earnings (PE) ratio of approximately 13.4, Vasundhara Rasy. trades at a moderate premium relative to many peers in its industry. Its price-to-book value stands at 1.71, indicating that the market values the company at nearly twice its book value. The enterprise value to EBITDA ratio of 14.8 further suggests a relatively elevated valuation, though not excessively so when compared to the broader pharmaceutical sector.

Return on capital employed (ROCE) and return on equity (ROE) are important indicators of operational efficiency and profitability. Vasundhara Rasy. posts a ROCE of 10.75% and an ROE of 12.74%, reflecting decent returns but not exceptional when benchmarked against industry leaders. The dividend yield of 1....

Read full news article

View All News